Artículos sobre Alzheimer
Artículos científicos publicados por los investigadores del Barcelonaβeta Brain Research Center (BBRC), relacionados con la enfermedad de Alzheimer, neuroimagen, memoria y enfermedades neurodegenerativas, entre otros campos.
-
Sala-Vila A, Tristão-Pereira C, Lázaro I, Shekari M, Fernández-Pena A, Monereo-Sánchez J, Garcia-Lunar I, Perez-Herreras C, Moro MA, Garcia-Alvarez A, Sanchez-Gonzalez J, Gispert JD, Ibanez B, Fuster V, Cortes-Canteli M.
Circulating palmitoleic acid is associated with cerebral glucose metabolism in healthy middle-aged individuals: results from the Progression of Early Subclinical Atherosclerosis prospective cohort study
The american journal of clinical nutritionAbstractBackground: Excess energy intake upregulates de novo lipogenesis (DNL). Circulating palmitoleic acid (POA) is an objective DNL biomarker associated with higher cardiovascular risk, which has been...
-
Arunachalam P, Pieperhoff L, Lorenzini L, Tranfa M, Masserini F, Treves F, Pontillo G, Preti MG, Broeders TAA, Schoonheim MM, Douw L, Ritchie C, Boada M, Marquié M, Visser PJ, Cacciaglia R, Gispert JD, Salvadó G, Luckett ES, Collij LE, Cole JH, Barkhof F, Wink AM; AMYPAD consortium.
Decreased amyloid-related structure-function coupling in preclinical Alzheimer's disease
Communications medicineAbstractBackground: Structural pathways of the brain facilitate functional communication, and their disruption in preclinical Alzheimer's disease may reflect network vulnerability and compensatory brain...
-
López-Martos D, Cacciaglia R, Suárez-Calvet M, Salvadó G, Shekari M, González-Escalante A, Milà-Alomà M, Brugulat-Serrat A, Minguillon C, Tonietto M, Borroni E, Klein G, Quijano-Rubio C, Kollmorgen G, Zetterberg H, Blennow K, Gispert JD, Grau-Rivera O, Sánchez-Benavides G; ALFA study.
Multimodal biomarker characterization of amnestic objective subtle cognitive decline in aging and preclinical Alzheimer's disease.
The journal of prevention of Alzheimer's DiseaseAbstractBackground: The objective of this study was to provide a multimodal biomarker characterization of amnestic objective subtle cognitive decline (obj-SCD) in aging and preclinical Alzheimer's disease (AD...
-
Grande G, Valletta M, Gasparini F, Vetrano DL, Canevelli M, Bacci JR, Qiu C, Marengoni A, Blasi MT, Xu H, Fratiglioni L, Mielke MM.
Brain pathology in relation to somatic diseases: Exploring the body-brain crosstalk
Journal of internal MedicineAbstractSeveral somatic diseases have been consistently linked with an increased dementia risk. However, the underlying neuropathological substrates remain poorly characterized. This narrative review aims to...
-
Serrano-Pozo A, Escott-Price V, Grinberg LT, Pascoal T, Suárez-Calvet M, Dubois B, Sperling RA.
Alzheimer's disease
LancetAbstractAlzheimer's disease is the leading cause of dementia and among the top ten leading causes of death in high-income countries. Exponential advances in epidemiology, genetics, diagnostic imaging and...
-
Suárez-Calvet M, Salvadó G, de Fortuny BB, Del Campo M.
Blood biomarkers for Alzheimer's disease: from detection to decisions
Lancet -
Ibáñez A, Yokoyama JS, Duran-Aniotz C, Miller BL; Multi-Partner Consortium to Expand Dementia Research in Latin America (ReDLat).
Genetic-exposome interactions and aging clocks in dementia: the ReDLat2 initiative
Nature Medicine -
Manzano Palomo MS, Terrón Cuadrado C, Gil Moreno MJ, Fernández García C, Alonso Bouzón C, Besga Basterra A, Brugulat-Serrat A, Teresa Carreras M, Castellanos Rodrigo M, Delgado Parada E, García Ribas G, Gramunt Fombuena N, Millán Pacheco A, Pagonabarraga Mora J, Porta Etessam J, Ramírez Díaz SP, Isabel Ramos García M, Rodríguez-Sánchez I, Salas Carrillo M, Sánchez-Benavides G, Simal Hernández P, Vieira Campos A.
Mild functional impairment: Definition and diagnostic criteria
Neurologia Engl EdAbstractIntroduction: The onset of mild functional impairment (MFI) is associated with greater progression to cognitive decline, in addition to influencing the course of other neurological, psychiatric, and...
-
Salvadó G, Horie K, Barthélemy NR, Schindler SE, Janelidze S, Orduña Dolado A, Bali D, Perrin RJ, Morris JC, Benzinger TLS, Gordon BA, Stomrud E, Mattsson-Carlgren N, Palmqvist S, Vogel JW, Bateman RJ, Ossenkoppele R, Hansson O
Plasma eMTBR-tau243 and %p-tau217 for Biological Staging of Alzheimer Disease
JAMA NeurologyAbstractImportance: Biological staging of Alzheimer disease (AD) can improve diagnostic accuracy and prognostic assessment. However, existing approaches often require invasive procedures and specialized...
-
Altschuler F, Castro-Laguardia AM, Canziani V, O'Byrne DF, Hazelton J, Migeot J, Maito M, García AM, Bruno MA, Magrath N, Slachevsky A, Behrens MI, Custodio N, Ávila-Funes JA, Matallana D, Aguillón D, Santamaria-García H, Resende E, Takada L, Brusco LI, Yokoyama JS, Miller B, Ibáñez A, Medel V, Campo CG.
Mapping the neurovascular landscape in aging and dementia: cerebral small vessel disease markers in a multicenter Latin American cohort
Alzheimer's & DementiaAbstractIntroduction: Cerebral small vessel disease (CSVD) is a key contributor to cognitive impairment and dementia, yet few studies have compared CSVD across dementia variants, particularly in...
